Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
802 studies found for:    "Hypertension, Pulmonary"
Show Display Options
Rank Status Study
21 Completed Pulmonary Hypertension--Mechanisms and Family Registry
Conditions: Lung Diseases;   Hypertension, Pulmonary
22 Completed Atorvastatin in Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Drug: Atorvastatin;   Drug: Placebo
23 Recruiting Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension
Condition: Hypertension, Pulmonary
24 Recruiting Acute Hemodynamic Effect of Acetazolamide in Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Drug: Acetazolamide;   Drug: Placebo
25 Recruiting EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat(BAY63-2521)
26 Active, not recruiting Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary Dysplasia
Conditions: Bronchopulmonary Dysplasia (BPD);   Hypertension, Pulmonary
27 Recruiting Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Riociguat for Chronic Thromboembolic Pulmonary Hypertension (CTEPH )
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat (ADEMPAS, BAY63-2521)
28 Completed Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Ventavis (Iloprost, BAYQ6256)
29 Active, not recruiting Chronic Thrombo-embolic Pulmonary Hypertension: Classification and Long Term Outcome
Conditions: Chronic Thromboembolic Pulmonary Hypertension;   Idiopathic Pulmonary Arterial Hypertension
30 Recruiting Pharmacodynamic Effects of Riociguat in Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction
Conditions: Hypertension, Pulmonary;   Heart Failure With Normal Ejection Fraction
Interventions: Drug: Riociguat;   Drug: Placebo
31 Unknown  Registry for Pulmonary Hypertension in China
Conditions: Pulmonary Arterial Hypertension;   Chronic Thromboembolic Pulmonary Hypertension;   Death
32 Terminated Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery
Conditions: Heart Diseases;   Hypertension, Pulmonary
Interventions: Drug: tezosentan;   Drug: placebo
33 Unknown  The Role of Endothelin in Pulmonary Hypertension
Condition: Pulmonary Hypertension
Intervention: Drug: BQ-123
34 Completed Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: epoprostenol
35 Unknown  Efficacy and Safety Study of Sodium Tanshinone IIA Sulfonate on Pulmonary Hypertension
Conditions: Pulmonary Hypertension;   Pulmonary Arterial Hypertension;   Cardiovascular Diseases;   Lung Diseases;   Tanshinone IIA Sulfonate
Interventions: Drug: 20 mg sildenafil citrate by mouth;   Drug: sodium tanshinone IIA sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth
36 Unknown  Latent Pulmonary Hypertension (PH) in Chronic Thromboembolic Pulmonary Hypertension (CTEPH )After Endarterectomy and Influence of Exercise and Respiratory Therapy
Conditions: Pulmonary Hypertension;   Chronic Thromboembolic Pulmonary Hypertension
Interventions: Behavioral: exercise and respiratory therapy;   Other: sedentary control group
37 Recruiting Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT
Conditions: Pulmonary Arterial Hypertension;   Pulmonary Hypertension
Interventions: Drug: Bardoxolone methyl;   Drug: Placebo
38 Recruiting Zürich Pulmonary Hypertension Outcome Assessment Cohort
Condition: Pulmonary Hypertension Outcome Assessment
Intervention: Other: PH target therapy according to physician
39 Completed Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Conditions: Systemic Sclerosis;   Scleroderma;   Pulmonary Hypertension;   Pulmonary Arterial Hypertension
40 Unknown  Genetic Research of Bone Morphogenetic Protein Receptor-II Gene in Taiwanese Patient With Primary Pulmonary Hypertension
Condition: Pulmonary Hypertension
Interventions: Procedure: for BMPR II study;   Genetic: BMPRII

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years